Daniel Abdun-Nabi, CEO at Emergent BioSolutions Inc. (EBS), sold 14,565 shares at $58.11 ($846K) on 2019-03-04, disclosed to the SEC on 2019-03-04.
Scheduled sale ($846k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EBS | SELL | 2018-09-06 | $5.5M | — | Filing → |
| EBS | SELL | 2018-06-07 | $823K | — | Filing → |
| EBS | SELL | 2018-01-04 | $1.0M | — | Filing → |